Precision Therapy Against Disease-Causing Plasma Cells
Antibodies protect our body – but they can also attack it. Researchers at the German Rheumatology Research Center (DRFZ), a Leibniz Institute, and Charité –…
Antibodies protect our body – but they can also attack it. Researchers at the German Rheumatology Research Center (DRFZ), a Leibniz Institute, and Charité –…
Carlo Veltri honored with prize for health services research Carlo Veltri was honored on September 9, 2026, during the opening ceremony of the German Rheumatology…
Rheumatology Monitor: A Dashboard for Rheumatology Dr. Johanna Callhoff, head of the Health Services Research Group at the DRFZ, was awarded one of the prizes…
Julia Polansky was selected by the Tagesspiegel Prof. Dr. Julia Polansky, Liaison group leader of the research group Immuno-Epigenetics at DRFZ and Professor for Immuno-Epigenetics…
An important milestone has been reached in the BMG-funded project “Linkage of Cancer Registry Data with Other Medical Registries” (LinkMedR): Data from medical registries and…
New insights into individual immune activation in SLE A research team from DRFZ and Charité – Universitätsmedizin Berlin has developed a novel method to investigate…
1.8 million people affected The number of people with inflammatory rheumatic diseases in Germany remains high at 2.6 percent, or 1.8 million people. The main…
Rethinking T Cells in Lupus Nephritis New insights into lupus nephritis suggest that kidney damage may be driven less by autoantigen-specific T cells than by…
